Jennifer Jahncke, Ph.D. (left), a postdoctoral scholar working in the lab of Kevin Wright, Ph.D. (right), has discovered a protein that provides insights into the neurological problems experienced by people with a rare form of muscular dystrophy known as dystroglycanopathy. (OHSU/Christine Torres Hicks)

Jennifer Jahncke, Ph.D., a postdoctoral scholar working in the lab of Kevin Wright, Ph.D., has discovered a protein that provides insights into the neurological problems experienced by people with a rare form of muscular dystrophy known as dystroglycanopathy. This image is of a Purkinje neuron (in red) – the business end of the cerebellum. The green dots are showing inhibitory synapses on the Purkinje neuron. Those synapses are the ones that lose functionality in animal models of dystroglycanopathy. (OHSU/Christine Torres Hicks)

La académica postdoctoral Jennifer Jahncke, Ph.D. (izq.), que trabaja en el laboratorio de Kevin Wright, Ph.D. (der.), ha descubierto una proteína que brinda conocimientos sobre los problemas neurológicos que experimentan las personas con una forma infrecuente de distrofia muscular conocida como distroglicanopatía. (OHSU/Christine Torres Hicks)

La académica postdoctoral Jennifer Jahncke, Ph.D., que trabaja en el laboratorio de Kevin Wright, Ph.D., ha descubierto una proteína que brinda conocimientos sobre los problemas neurológicos que experimentan las personas con una forma infrecuente de distrofia muscular conocida como distroglicanopatía. (OHSU/Christine Torres Hicks)

The Oregon Health & Science University Knight Cancer Institute has awarded funding to 12 organizations across Oregon to address various cancer-related needs, continuing its investment in community support through the Community Partnership Program, which has allocated over $6.4 million since 2014. (OHSU)

Clockwise from top left: Ella Bowman, M.D., Ph.D., Sima Desai, M.D., Shelly Tworoger, Ph.D., Vijayshree Yadav, M.D., Jeff Tyner, Ph.D., and Erin Maynard, M.D. (OHSU)